SCHEMBL31523571

SCHEMBL31523571

COc1c(NN)cc(F)c(Br)c1F

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.34
▸ CA4 P22748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1785242 0.83 HSD17B10 (0.32) CA2
SCHEMBL31248689 0.76 CA2 (0.38) CA2CA4
SCHEMBL6736519 0.75 CA2 (0.40) CA2CA4
SCHEMBL31523339 0.73 ALOX5AP (0.39) CA2CA4
Hydrochloric Acid SCHEMBL31523285 0.71 ALOX5AP (0.38) CA2CA4
Hydrochloric Acid SCHEMBL25343166 0.70 JAK2 (0.36) CA2
Hydrochloric Acid SCHEMBL15561316 0.70 MAPT (0.34) CA2
Hydrochloric Acid SCHEMBL15561625 0.68 GAA (0.34) —
SCHEMBL10568715 0.66 HTR2A (0.43) —
SCHEMBL7042377 0.66 CA2 (0.39) CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054488-A1 TRICYCLIC DERIVATIVES AND RELATED USES MOMA THERAPEUTICS, INC. (US) 2025-03-13 — — WO disclosed
Send feedback